What’s Driving Growth in the Implantable Cardioverter Defibrillators (ICDs) Market? Insights into Key Trends and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the implantable cardioverter defibrillators (icds) market grown in recent years?
The market for implantable cardioverter defibrillators (ICDs) has seen robust growth in the past few years. It is projected to expand from $3.76 billion in 2024 to $3.99 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.0%. This growth in the past years can be traced back to factors like a rise in sudden cardiac arrest occurrences, the use of implantable cardioverter defibrillator in preventing secondary sudden cardiac arrest episodes, heightened public consciousness, an increase in the elderly population, supportive government policies and healthcare initiatives, and improved healthcare accessibility.
How is the implantable cardioverter defibrillators (icds) market size expected to evolve during the forecast period?
The market for implantable cardioverter defibrillators (ICDs) is set to experience strong expansion in the coming years, projecting growth to $4.99 billion in 2029 with a compound annual growth rate (CAGR) of 5.8%. This predicted growth can be linked to the increasing acceptance of implantable defibrillators, a surge in the need for individualized cardiac care, escalating occurrence of cardiac rhythm disorders, and a growing demand in budding markets. Key trends anticipated during this forecast period encompass technological progress, the launch of subcutaneous ICDs that eliminate the need for transvenous leads, the demand for combination ICD devices with pacemaker functionality, enhanced sensing and detection algorithms, ongoing advancements in wireless charging and battery technology, and the incorporation of artificial intelligence (AI) in healthcare and data analytics.
Get your implantable cardioverter defibrillators (icds) market report here!
Which key drivers are propelling the implantable cardioverter defibrillators (icds) market’s growth?
The escalating occurrence of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the market for implantable cardioverter defibrillators (ICDs). Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels like, heart attacks, strokes, hypertension, etc, often resulting from unhealthy food habits, lack of physical activity, tobacco use and hereditary gene factors. The surge in cardiovascular diseases mainly stems from aging populations, unhealthy lifestyle habits, and increasing instances of risk contributors such as obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) play a significant role in managing cardiovascular diseases by delivering the crucial electric shocks required to reset the normal heart rhythm, in patients susceptible to unexpected cardiac arrests. For example, a report by the Australian Institute of Health and Welfare, a government agency based in Australia, stated that in December 2023, medically approved deaths due to coronary heart disease saw an escalation from 14,100 in 2021 to 14,900 in 2022. Consequently, the escalating occurrence of cardiovascular diseases (CVDs) is fuelling the growth of the market for implantable cardioverter defibrillators (ICDs).
What are the market segments in the implantable cardioverter defibrillators (icds) industry?
The implantable cardioverter defibrillators (ICDs) market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices
2) By Applications: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), CRT-P (Cardiac Resynchronization Therapy Pacemaker), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
Which leading companies are shaping the growth of the implantable cardioverter defibrillators (icds) market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.
What are the key trends shaping the future of the implantable cardioverter defibrillators (icds) market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are focusing on technological advancements, such as low current consumption defibrillators, to enhance device efficiency, extend battery life, and improve patient comfort. Low current consumption defibrillators are designed to deliver electrical shocks to the heart using less energy, which helps prolong battery life while ensuring effective treatment of arrhythmias. For instance, in October 2023, MicroPort CRM, a France-based medical devices company, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a notable advancement in cardiac care technology. These devices feature innovative capabilities, such as low current consumption for prolonged battery life and MRI compatibility, ensuring they are suitable for patients needing imaging procedures. The ULYS ICD includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, enhancing patient safety during MRI scans. Additionally, the INVICTA lead achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, highlighting its reliability and effectiveness.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839
Which geographic areas are influencing the growth of the implantable cardioverter defibrillators (icds) market?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Implantable Defibrillators Global Market Report 2025
https://thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report
Automated External Defibrillators (AED) Global Market Report 2025
Implantable Infusion Pumps Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
